Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K M Stenson

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Archives of Otolaryngology--Head & Neck Surgery|August 2, 2000
The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissectionK M Stenson, D J Haraf, H Pelzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2008
Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinomaB R Knab, J K Salama, A Solanki, et al.
Oral Oncology|October 30, 2012
Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinomaD W Golden, S Rudra, M E Witt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2011
A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancersJ K Salama, D J Haraf, K M Stenson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2008
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levelsJ K Salama, K M Stenson, E O Kistner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experienceB Brockstein, D J Haraf, A W Rademaker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2011
Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neckV M Villaflor, D Haraf, J K Salama, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2016
Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancerV M Villaflor, J M Melotek, T G Karrison, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Archives of Otolaryngology--Head & Neck Surgery|August 2, 2000
The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissectionK M Stenson, D J Haraf, H Pelzer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2008
Functional organ preservation with definitive chemoradiotherapy for T4 laryngeal squamous cell carcinomaB R Knab, J K Salama, A Solanki, et al.
Oral Oncology|October 30, 2012
Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinomaD W Golden, S Rudra, M E Witt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2011
A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancersJ K Salama, D J Haraf, K M Stenson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 10, 2008
Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi-institutional phase II trial investigating three radiotherapy dose levelsJ K Salama, K M Stenson, E O Kistner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experienceB Brockstein, D J Haraf, A W Rademaker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 10, 2011
Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neckV M Villaflor, D Haraf, J K Salama, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2016
Response-adapted volume de-escalation (RAVD) in locally advanced head and neck cancerV M Villaflor, J M Melotek, T G Karrison, et al.
Pageof 2